Northwestern Mutual Investment Management Company’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.03M Buy
39,807
+109
+0.3% +$14.4K 0.06% 102
2026
Q1
$5.53M Buy
39,698
+55
+0.1% +$7.7K 0.08% 73
2025
Q4
$4.87M Buy
39,643
+96
+0.2% +$11.7K 0.06% 89
2025
Q3
$4.39M Sell
39,547
-136
-0.3% -$15.5K 0.06% 98
2025
Q2
$4.4M Buy
39,683
+46
+0.1% +$4.9K 0.07% 83
2025
Q1
$4.44M Buy
39,637
+67
+0.2% +$6.91K 0.07% 73
2024
Q4
$3.66M Buy
39,570
+112
+0.3% +$10.1K 0.08% 102
2024
Q3
$3.31M Sell
39,458
-190
-0.5% -$14.5K 0.08% 122
2024
Q2
$2.72M Buy
39,648
+111
+0.3% +$7.41K 0.07% 144
2024
Q1
$2.9M Buy
39,537
+96
+0.2% +$7.38K 0.08% 134
2023
Q4
$3.2M Buy
39,441
+112
+0.3% +$8.72K 0.08% 102
2023
Q3
$2.95M Sell
39,329
-16
-0% -$1.23K 0.08% 94
2023
Q2
$3.03M Buy
39,345
+146
+0.4% +$11.6K 0.08% 97
2023
Q1
$3.25M Sell
39,199
-113
-0.3% -$9.36K 0.08% 84
2022
Q4
$3.37M Sell
39,312
-7,239
-16% -$573K 0.09% 78
2022
Q3
$2.87M Sell
46,551
-8,915
-16% -$562K 0.07% 90
2022
Q2
$3.43M Sell
55,466
-46
-0.1% -$2.85K 0.08% 97
2022
Q1
$3.3M Sell
55,512
-6,613
-11% -$423K 0.07% 120
2021
Q4
$4.51M Sell
62,125
-714
-1% -$49.2K 0.09% 109
2021
Q3
$4.39M Buy
62,839
+5,884
+10% +$413K 0.09% 104
2021
Q2
$3.92M Sell
56,955
-10
-0% -$668 0.07% 113
2021
Q1
$3.68M Sell
56,965
-11,827
-17% -$763K 0.06% 112
2020
Q4
$4.01M Sell
68,792
-96
-0.1% -$5.79K 0.05% 140
2020
Q3
$5.3M Hold
68,888
0.07% 81
2020
Q2
$5.3M Sell
68,888
-111,576
-62% -$8.55M 0.07% 79
2020
Q1
$13.5M Buy
180,464
+131,320
+267% +$9.07M 0.2% 49
2019
Q4
$3.19M Buy
49,144
+915
+2% +$59.6K 0.06% 117
2019
Q3
$3.06M Sell
48,229
-2
-0% -$131 0.07% 115
2019
Q2
$3.26M Sell
48,231
-145,590
-75% -$9.58M 0.08% 106
2019
Q1
$12.6M Sell
193,821
-1,240
-0.6% -$82.4K 0.23% 88
2018
Q4
$12.2M Sell
195,061
-31,787
-14% -$2.22M 0.2% 88
2018
Q3
$17.5M Sell
226,848
-22,146
-9% -$1.67M 0.27% 84
2018
Q2
$17.6M Buy
248,994
+10,549
+4% +$745K 0.26% 73
2018
Q1
$18M Sell
238,445
-56,608
-19% -$4.5M 0.3% 65
2017
Q4
$21.1M Sell
295,053
-5,876
-2% -$446K 0.35% 59
2017
Q3
$24.4M Buy
300,929
+1,068
+0.4% +$81.7K 0.4% 51
2017
Q2
$21.2M Buy
299,861
+35,647
+13% +$2.37M 0.36% 50
2017
Q1
$17.9M Buy
264,214
+112,932
+75% +$7.94M 0.32% 53
2016
Q4
$10.8M Buy
151,282
+20,725
+16% +$1.54M 0.21% 53
2016
Q3
$10.3M Buy
130,557
+79,746
+157% +$6.48M 0.22% 50
2016
Q2
$4.24M Sell
50,811
-1,380
-3% -$122K 0.09% 121
2016
Q1
$4.79M Sell
52,191
-2,558
-5% -$231K 0.1% 121
2015
Q4
$5.54M Buy
54,749
+347
+0.6% +$36.1K 0.12% 120
2015
Q3
$5.34M Sell
54,402
-685
-1% -$76.1K 0.11% 117
2015
Q2
$6.45M Buy
55,087
+625
+1% +$68.3K 0.13% 127
2015
Q1
$5.34M Buy
+54,462
New +$5.53M 0.11% 141

Other funds holding GILD

Northwestern Mutual Investment Management Company's GILD Position: Q2 2026 in Review

Northwestern Mutual Investment Management Company increased its Gilead Sciences (GILD) stake by 0.27% in Q2 2026, buying an estimated $14.4K and bringing the position to 39,807 shares worth $5.03M. The position accounts for 0.06% of the portfolio, ranked #102.

Northwestern Mutual Investment Management Company first reported a position in GILD in Q1 2015 and has held it in 46 quarters since. The position peaked at $24.4M in Q3 2017. 1,756 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Northwestern Mutual Investment Management Company held 39,807 shares of Gilead Sciences worth $5.03M as of Q2 2026.
  • Northwestern Mutual Investment Management Company bought 109 Gilead Sciences shares in Q2 2026, an estimated $14.4K.
  • Gilead Sciences made up 0.06% of Northwestern Mutual Investment Management Company's portfolio in Q2 2026, its #102 holding.
  • Northwestern Mutual Investment Management Company first reported a position in Gilead Sciences in Q1 2015 and has held it in 46 quarters since.
  • Northwestern Mutual Investment Management Company's Gilead Sciences position peaked at $24.4M in Q3 2017.
  • 1,756 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Northwestern Mutual Investment Management Company's 13F filing for Q2 2026, filed 12 Aug 2026.